Article Details
Retrieved on: 2024-06-19 19:23:29
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A novel “armored” chimeric antigen receptor (CAR) T cell appears to be feasible for retreatment of patients with non-Hodgkin lymphoma (NHL) who ...
Article found on: ascopost.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here